Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	Books, Journals, Podcasts, Weekly Updates, by Amedeo

Colorectal Neoplasms

Free Subscription Articles published in Anticancer Res Retrieve available abstracts of 98 articles: HTML format Text format

Single Articles

January 2010
1. ALDULAYMI B , Christensen IJ, Soletormos G, Jess P, et al
   Changes in Soluble CEA and TIMP-1 Levels during Adjuvant Chemotherapy for Stage III Colon Cancer.
   Anticancer Res. 2010;30:233-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. DEBRUYNE D , Leroy A, DE Wever O, Vakaet L, et al
   Direct Effects of Delta Opioid Receptor Agonists on Invasion-associated Activities of HCT-8/E11 Colon Cancer Cells.
   Anticancer Res. 2010;30:9-17.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. DIONNE S , Levy E, Levesque D, Seidman EG, et al
   PPARgamma ligand 15-deoxy-delta 12,14-prostaglandin J2 sensitizes human colon carcinoma cells to TWEAK-induced apoptosis.
   Anticancer Res. 2010;30:157-66.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. CHEN MH , Chang CH, Chang YJ, Chen LC, et al
   MicroSPECT/CT Imaging and Pharmacokinetics of 188Re-(DXR)-liposome in Human Colorectal Adenocarcinoma-bearing Mice.
   Anticancer Res. 2010;30:65-72.
   PubMed     Text format     Related articles    Abstract available
   
   
   December 2009
5. GIANNOPOULOU E , Antonacopoulou A, Matsouka P, Kalofonos HP, et al
   Autophagy: novel action of panitumumab in colon cancer.
   Anticancer Res. 2009;29:5077-82.
   PubMed     Text format     Related articles    Abstract available
   
   
   November 2009
6. DE OLIVEIRA AT , Matos D, Logullo AF, DA Silva SR, et al
   MET Is Highly Expressed in Advanced Stages of Colorectal Cancer and Indicates Worse Prognosis and Mortality.
   Anticancer Res. 2009;29:4807-11.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. BOWEN KA , Doan HQ, Zhou BP, Wang Q, et al
   PTEN Loss Induces Epithelial--Mesenchymal Transition in Human Colon Cancer Cells.
   Anticancer Res. 2009;29:4439-49.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. SCHJOLBERG AR , Clausen OP, Burum-Auensen E, DE Angelis PM, et al
   Aneuploidy Is Associated with TP53 Expression but not with BRCA1 or TERT Expression in Sporadic Colorectal Cancer.
   Anticancer Res. 2009;29:4381-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. MAESTRO LM , Sastre J, Rafael SB, Veganzones SB, et al
   Circulating tumor cells in solid tumor in metastatic and localized stages.
   Anticancer Res. 2009;29:4839-43.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MELICHAR B , Kalabova H, Krcmova L, Kasparova M, et al
    Serum homocysteine, cholesterol, retinol, alpha-tocopherol, glycosylated hemoglobin and inflammatory response during therapy with bevacizumab, oxaliplatin, 5-fluorouracil and leucovorin.
    Anticancer Res. 2009;29:4813-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. BENES Z , Antos Z
    Optical biopsy system distinguishing between hyperplastic and adenomatous polyps in the colon during colonoscopy.
    Anticancer Res. 2009;29:4737-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
12. SASSA S , Okabe H, Nemoto N, Kikuchi H, et al
    Ibadronate may prevent colorectal carcinogenesis in mice with ulcerative colitis.
    Anticancer Res. 2009;29:4615-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CABIBI D , Calascibetta A, Aragona F, Martorana A, et al
    Differing expression of metalloprotease and of adhesion molecules in signet-ring cell and intestinal colorectal carcinoma.
    Anticancer Res. 2009;29:4417-22.
    PubMed     Text format     Related articles    Abstract available
    
    
    October 2009
14. PARK IJ , Choi GS, Jun SH
    Prognostic Value of Serum Tumor Antigen CA19-9 After Curative Resection of Colorectal Cancer.
    Anticancer Res. 2009;29:4303-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. RUBIO CA , Kapraali M, Befrits R
    Further studies on the frequency of colorectal cancer in Crohn's colitis: an 11-year survey in the northwest stockholm county.
    Anticancer Res. 2009;29:4291-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. BALTAZIAK M , Koda M, Wincewicz A, Sulkowska M, et al
    Relationships of P53 and Bak with EPO and EPOR in Human Colorectal Cancer.
    Anticancer Res. 2009;29:4151-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. PALOMARES T , Carames M, Garcia-Alonso I, Alonso-Varona A, et al
    Glutathione Modulation Reverses the Growth-promoting Effect of Growth Factors, Improving the 5-Fluorouracil Antitumour Response in WiDr Colon Cancer Cells.
    Anticancer Res. 2009;29:3957-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
18. SAKURABA K , Yasuda T, Sakata M, Kitamura YH, et al
    Down-regulation of Tip60 Gene as a Potential Marker for the Malignancy of Colorectal Cancer.
    Anticancer Res. 2009;29:3953-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. LIU D , Overbey D, Watkinson LD, Daibes-Figueroa S, et al
    In vivo imaging of human colorectal cancer using radiolabeled analogs of the uroguanylin Peptide hormone.
    Anticancer Res. 2009;29:3777-83.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2009
20. BROZEK W , Kriwanek S, Bonner E, Peterlik M, et al
    Mutual associations between malignancy, age, gender, and subsite incidence of colorectal cancer.
    Anticancer Res. 2009;29:3721-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. CROSS HS , Nittke T, Peterlik M
    Modulation of vitamin D synthesis and catabolism in colorectal mucosa: a new target for cancer prevention.
    Anticancer Res. 2009;29:3705-12.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
22. CHIRUMBOLE M , Gusani N, Howard A, Leonard T, et al
    A comparison of stage of presentation for pancreatic and colorectal cancer in Pennsylvania 2000-2005.
    Anticancer Res. 2009;29:3427-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
23. PALMIROTTA R , Savonarola A, Formica V, Ludovici G, et al
    A novel K-ras mutation in colorectal cancer. A case report and literature review.
    Anticancer Res. 2009;29:3369-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    
24. GUADAGNI F , Roselli M, Martini F, Spila A, et al
    Prognostic significance of serum adipokine levels in colorectal cancer patients.
    Anticancer Res. 2009;29:3321-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. JAPINK D , Leers MP, Sosef MN, Nap M, et al
    CEA in activated macrophages. New diagnostic possibilities for tumor markers in early colorectal cancer.
    Anticancer Res. 2009;29:3245-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. STACHTEA X , Karamanos N, Klouras N
    Enhanced antitumour activity of cyclopendadienyl-substituted metallocene dihalides in human breast and colon cancer cells.
    Anticancer Res. 2009;29:3227-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. GUZINSKA-USTYMOWICZ K , Pryczynicz A, Kemona A, Czyzewska J, et al
    Correlation between proliferation markers: PCNA, Ki-67, MCM-2 and antiapoptotic protein Bcl-2 in colorectal cancer.
    Anticancer Res. 2009;29:3049-52.
    PubMed     Text format     Related articles    Abstract available
    
    
    
28. CHAN JY , Tan BK, Lee SC
    Scutellarin sensitizes drug-evoked colon cancer cell apoptosis through enhanced caspase-6 activation.
    Anticancer Res. 2009;29:3043-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. KIM JC , Shin ES, Kim CW, Roh SA, et al
    In vitro evaluation of histone deacetylase inhibitors as combination agents for colorectal cancer.
    Anticancer Res. 2009;29:3027-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. LIU JJ , Duan RD
    LY294002 enhances boswellic acid-induced apoptosis in colon cancer cells.
    Anticancer Res. 2009;29:2987-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. AMBROSINO G , Polistina F, Costantin G, Francescon P, et al
    Image-guided robotic stereotactic radiosurgery for unresectable liver metastases: preliminary results.
    Anticancer Res. 2009;29:3381-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
32. JOHNSON SM , Gulhati P, Arrieta I, Wang X, et al
    Curcumin inhibits proliferation of colorectal carcinoma by modulating Akt/mTOR signaling.
    Anticancer Res. 2009;29:3185-90.
    PubMed     Text format     Related articles    Abstract available
    
    
    
33. KIM JC , Roh SA, Cho DH, Kim TW, et al
    Chemoresponsiveness associated with canonical molecular changes in colorectal adenocarcinomas.
    Anticancer Res. 2009;29:3115-23.
    PubMed     Text format     Related articles    Abstract available
    
    
    
34. RETI A , Pap E, Zalatnai A, Jeney A, et al
    Co-inhibition of cyclooxygenase-2 and dihydropyrimidine dehydrogenase by non-steroidal anti-inflammatory drugs in tumor cells and xenografts.
    Anticancer Res. 2009;29:3095-101.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. WANG CZ , Li XL, Sun S, Xie JT, et al
    Methylnaltrexone, a peripherally acting opioid receptor antagonist, enhances tumoricidal effects of 5-Fu on human carcinoma cells.
    Anticancer Res. 2009;29:2927-32.
    PubMed     Text format     Related articles    Abstract available
    
    
    
36. RESTUCCI B , Martano M, DE Vico G, Lo Muzio L, et al
    Expression of E-cadherin, beta-catenin and APC protein in canine colorectal tumours.
    Anticancer Res. 2009;29:2919-25.
    PubMed     Text format     Related articles    Abstract available
    
    
    July 2009
37. TRIANTAFILLIDIS JK , Nasioulas G, Kosmidis PA
    Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies.
    Anticancer Res. 2009;29:2727-37.
    PubMed     Text format     Related articles    Abstract available
    
    
    
38. HAZAMA S , Watanabe S, Ohashi M, Yagi M, et al
    Efficacy of Orally Administered Superfine Dispersed Lentinan ({beta}-1,3-Glucan) for the Treatment of Advanced Colorectal Cancer.
    Anticancer Res. 2009;29:2611-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
39. MONTEIL J , Mahmoudi N, Leobon S, Roudaut PY, et al
    Chemotherapy Response Evaluation in Metastatic Colorectal Cancer with FDG PET/CT and CT Scans.
    Anticancer Res. 2009;29:2563-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. DOAN HQ , Bowen KA, Jackson LA, Evers BM, et al
    Toll-like Receptor 4 Activation Increases Akt Phosphorylation in Colon Cancer Cells.
    Anticancer Res. 2009;29:2473-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. MA H , DAS T, Pereira S, Yang Z, et al
    Efficacy of dietary antioxidants combined with a chemotherapeutic agent on human colon cancer progression in a fluorescent orthotopic mouse model.
    Anticancer Res. 2009;29:2421-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    June 2009
42. YANG MD , Hsu YM, Kuo YS, Chen HS, et al
    Significant Association of Ku80 Single Nucleotide Polymorphisms with Colorectal Cancer Susceptibility in Central Taiwan.
    Anticancer Res. 2009;29:2239-2242.
    PubMed     Text format     Related articles    Abstract available
    
    
    
43. HIBI K , Sakata M, Kitamura YH, Sakuraba K, et al
    Demethylation of the CD133 Gene Is Frequently Detected in Advanced Colorectal Cancer.
    Anticancer Res. 2009;29:2235-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. HIBI K , Goto T, Mizukami H, Kitamura YH, et al
    Demethylation of the CDH3 Gene Is Frequently Detected in Advanced Colorectal Cancer.
    Anticancer Res. 2009;29:2215-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. TORIGOE S , Ogata Y, Matono K, Shirouzu K, et al
    Molecular Mechanisms of Sequence-dependent Antitumor Effects of SN-38 and 5-Fluorouracil Combination Therapy against Colon Cancer Cells.
    Anticancer Res. 2009;29:2083-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. TANAKA H , Nakamura M, Kameda C, Kubo M, et al
    The Hedgehog Signaling Pathway Plays an Essential Role in Maintaining the CD44+CD24-/low Subpopulation and the Side Population of Breast Cancer Cells.
    Anticancer Res. 2009;29:2147-57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
47. CHOW TH , Lin YY, Hwang JJ, Wang HE, et al
    Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Anticancer Res. 2009;29:2111-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
48. NAKAYAMA Y , Inoue Y, Minagawa N, Onitsuka K, et al
    Chemopreventive effect of 4-[3,5-Bis(trimethylsilyl) benzamido] benzoic acid (TAC-101) on MNU-induced colon carcinogenesis in a rat model.
    Anticancer Res. 2009;29:2059-65.
    PubMed     Text format     Related articles    Abstract available
    
    
    
49. HAN Z , Dimas K, Tian X, Wang Y, et al
    14-3-3sigma-dependent resistance to cisplatin.
    Anticancer Res. 2009;29:2009-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. TONRA JR , Corcoran E, Deevi DS, Steiner P, et al
    Prioritization of EGFR/IGF-IR/VEGFR2 combination targeted therapies utilizing cancer models.
    Anticancer Res. 2009;29:1999-2007.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. SIEMANN DW , Norris CM, Ryan A, Shi W, et al
    Impact of tumor cell VEGF expression on the in vivo efficacy of vandetanib (ZACTIMA; ZD6474).
    Anticancer Res. 2009;29:1987-92.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
52. OGAWA M , Watanabe M, Eto K, Omachi T, et al
    Clinicopathological features of perforated colorectal cancer.
    Anticancer Res. 2009;29:1681-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. DES GUETZ G , Uzzan B, Nicolas P, Schischmanoff O, et al
    Microsatellite Instability does not Predict the Efficacy of Chemotherapy in Metastatic Colorectal Cancer. A Systematic Review and Meta-analysis.
    Anticancer Res. 2009;29:1615-20.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. RUBIO CA , Lenander C
    Different biological materials are found in neoplastic glands with pores at the invading edge of sporadic colonic carcinomas.
    Anticancer Res. 2009;29:1745-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. ZUPA A , Sgambato A, Bianchino G, Improta G, et al
    GSTM1 and NAT2 Polymorphisms and Colon, Lung and Bladder Cancer Risk: A Case-control Study.
    Anticancer Res. 2009;29:1709-14.
    PubMed     Text format     Related articles    Abstract available
    
    
    
56. CHECK JH , Dix E, Sansoucie L, Check D, et al
    Mifepristone may halt progression of extensively metastatic human adenocarcinoma of the colon - case report.
    Anticancer Res. 2009;29:1611-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. MURTHAIAH P , Truskinovsky AM, Shah S, Dudek AZ, et al
    Collision tumor versus multiphenotypic differentiation: a case of carcinoma with features of colonic and lung primary tumors.
    Anticancer Res. 2009;29:1495-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. LJUSLINDER I , Malmer B, Isaksson-Mettavainio M, Oberg A, et al
    ErbB 1-4 expression alterations in primary colorectal cancers and their corresponding metastases.
    Anticancer Res. 2009;29:1489-94.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
59. PAPADOKOSTOPOULOU A , Mathioudaki K, Scorilas A, Xynopoulos D, et al
    Colon cancer and protein arginine methyltransferase 1 gene expression.
    Anticancer Res. 2009;29:1361-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
60. RIEMANN K , Struwe H, Alakus H, Obermaier B, et al
    Association of GNB4 intron-1 haplotypes with survival in patients with UICC stage III and IV colorectal carcinoma.
    Anticancer Res. 2009;29:1271-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
61. HUO Q , Kinugasa T, Wang L, Huang J, et al
    Claudin-1 Protein is a Major Factor Involved in the Tumorigenesis of Colorectal Cancer.
    Anticancer Res. 2009;29:851-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
62. THEODOROPOULOS GE , Karafoka E, Papailiou JG, Stamopoulos P, et al
    P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Anticancer Res. 2009;29:785-91.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. BIR AS , Fora AA, Levea C, Fakih MG, et al
    Spontaneous regression of colorectal cancer metastatic to retroperitoneal lymph nodes.
    Anticancer Res. 2009;29:465-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
64. BOROSENKO V , Irmejs A, Melbarde-Gorkusa I, Gardovskis A, et al
    Initial results of colorectal polyposis research in Latvia.
    Anticancer Res. 2009;29:711-5.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. RUBIO CA
    Further studies support the participation of stem cells in the cell turnover of duodenal adenomas.
    Anticancer Res. 2009;29:657-60.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. NOJIRI K , Nagano Y, Tanaka K, Matsuo K, et al
    Validity of hepatic resection of colorectal liver metastases in the elderly (75 years and older).
    Anticancer Res. 2009;29:583-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    January 2009
67. FLIS S , Splwinski J
    Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.
    Anticancer Res. 2009;29:435-41.
    PubMed     Text format     Related articles    Abstract available
    
    
    
68. GIRI B , Gomes A, Sengupta R, Banerjee S, et al
    Curcumin synergizes the growth inhibitory properties of Indian toad (Bufo melanostictus Schneider) skin-derived factor (BM-ANF1) in HCT-116 colon cancer cells.
    Anticancer Res. 2009;29:395-401.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. GOTO T , Mizukami H, Shirahata A, Sakata M, et al
    Aberrant methylation of the p16 gene is frequently detected in advanced colorectal cancer.
    Anticancer Res. 2009;29:275-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. HIBI K , Mizukami H, Shirahata A, Goto T, et al
    Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
    Anticancer Res. 2009;29:271-3.
    PubMed     Text format     Related articles    Abstract available
    
    
    
71. XU R , Sato N, Yanai K, Akiyoshi T, et al
    Enhancement of paclitaxel-induced apoptosis by inhibition of mitogen-activated protein kinase pathway in colon cancer cells.
    Anticancer Res. 2009;29:261-70.
    PubMed     Text format     Related articles    Abstract available
    
    
    
72. WU WK , Tse TT, Sung JJ, Li ZJ, et al
    Expression of ErbB receptors and their cognate ligands in gastric and colon cancer cell lines.
    Anticancer Res. 2009;29:229-34.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. KOLINSKY K , Zhang YE, Dugan U, Heimbrook D, et al
    Novel regimens of capecitabine alone and combined with irinotecan and bevacizumab in colorectal cancer xenografts.
    Anticancer Res. 2009;29:91-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. FREDERIKSEN C , Lomholt AF, Davis GJ, Dowell BL, et al
    Changes in plasma TIMP-1 levels after resection for primary colorectal cancer.
    Anticancer Res. 2009;29:75-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. HIGASHIJIMA J , Shimada M, Chikakiyo M, Miyatani T, et al
    Effect of splenectomy on antitumor immune system in mice.
    Anticancer Res. 2009;29:385-93.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. HSU CP , Lin YH, Chou CC, Zhou SP, et al
    Mechanisms of grape seed procyanidin-induced apoptosis in colorectal carcinoma cells.
    Anticancer Res. 2009;29:283-9.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. SHIRAHATA A , Sakata M, Sakuraba K, Goto T, et al
    Vimentin methylation as a marker for advanced colorectal carcinoma.
    Anticancer Res. 2009;29:279-81.
    PubMed     Text format     Related articles    Abstract available
    
    
    
78. BUHMEIDA A , Hilska M, Elzagheid A, Laato M, et al
    DNA image cytometry predicts disease outcome in stage II colorectal carcinoma.
    Anticancer Res. 2009;29:99-106.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. GENTNER B , Wein A, Croner RS, Zeittraeger I, et al
    Differences in the gene expression profile of matrix metalloproteinases (MMPs) and their inhibitors (TIMPs) in primary colorectal tumors and their synchronous liver metastases.
    Anticancer Res. 2009;29:67-74.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2008
80. HALAMA N , Herrmann C, Jaeger D, Herrmann T, et al
    Treatment with cetuximab, bevacizumab and irinotecan in heavily pretreated patients with metastasized colorectal cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. TSOUMA A , Aggeli C, Pissimissis N, Lembessis P, et al
    Circulating tumor cells in colorectal cancer: detection methods and clinical significance.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. DE IUDICIBUS S , De Pellegrin A, Stocco G, Bartoli F, et al
    ABCB1 gene polymorphisms and expression of P-glycoprotein and long-term prognosis in colorectal cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
83. BENDARDAF R , Buhmeida A, Hilska M, Laato M, et al
    VEGF-1 expression in colorectal cancer is associated with disease localization, stage, and long-term disease-specific survival.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. TSANOU E , Peschos D, Batistatou A, Charalabopoulos A, et al
    The E-cadherin adhesion molecule and colorectal cancer. A global literature approach.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. BATHEN TF , Holmgren K, Lundemo AG, Hjelstuen MH, et al
    Omega-3 fatty acids suppress growth of SW620 human colon cancer xenografts in nude mice.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. TAKAYA Y , Tanaka K, Hirakawa C, Tagawa Y, et al
    New method for separation of subpopulations from a heterogeneous colon cancer cell line.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
87. ZEITOUN G , Mourra N, Blanche-Koch H, Thomas G, et al
    Genomic profile of colon cancer metastases.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
88. TAKANO S , Kubota T, Nishibori H, Hasegawa H, et al
    Pioglitazone, a ligand for peroxisome proliferator-activated receptor-gamma acts as an inhibitor of colon cancer liver metastasis.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
89. THANT AA , Wu Y, Lee J, Mishra DK, et al
    Role of caspases in 5-FU and selenium-induced growth inhibition of colorectal cancer cells.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
90. PASETTO LM , Friso ML, Pucciarelli S, Basso U, et al
    Role of neoadjuvant treatment in cT3N0M0 rectal cancer.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. PASETTO LM , Sinigaglia G, Basso U, Cocchio S, et al
    Neoadjuvant chemoradiotherapy with 5-fluorouracil by bolus.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. FEMIA AP , Paulsen JE, Dolara P, Alexander J, et al
    Correspondence between flat aberrant crypt foci and mucin-depleted foci in rodent colon carcinogenesis.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. ZHANG P , Li B, Gao S, Duan RD, et al
    Dietary sphingomyelin inhibits colonic tumorigenesis with an up-regulation of alkaline sphingomyelinase expression in ICR mice.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    September 2008
94. ASHKTORAB H , Tsang S, Luke B, Sun Z, et al
    Protective effect of Cox-2 allelic variants on risk of colorectal adenoma development in African Americans.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. SHAO YY , Hong RL
    Fatal thrombocytopenia after oxaliplatin-based chemotherapy.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
96. KOUKOURAKIS MI , Simopoulos C, Pitiakoudis M, Lyratzopoulos N, et al
    Hypofractionated accelerated radiotherapy, cytoprotection and capecitabine in the treatment of rectal cancer: a feasibility study.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
97. MURAYAMA M , Tanaka Y, Yagi J, Uchiyama T, et al
    Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. CALZOLARI F , Sartori PV, Talarico C, Parmeggiani D, et al
    Surgical treatment of intrathyroid metastases: preliminary results of a multicentric study.
    Anticancer Res. 2008;28.
    PubMed     Text format     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: